In animals, circadian behavior can be analyzed as an integrated system, beginning with genes and leading ultimately to behavioral outputs. In the last decade, the molecular mechanism of circadian clocks has been unraveled primarily by the use of phenotype-driven (forward) genetic analysis in a number of model systems. Circadian oscillations are generated by a set of genes forming a transcriptional autoregulatory feedback loop. In mammals, there is a "core" set of circadian genes that form the primary negative feedback loop of the clock mechanism (Clock/Npas2, Bmal1, Per1, Per2, Cry1, Cry2, and CK1ε). A further dozen candidate genes have been identified and have additional roles in the circadian gene network such as the feedback loop involving Rev-erbα. Despite this remarkable progress, it is clear that a significant number of genes that strongly influence and regulate circadian rhythms in mammals remain to be discovered and identified. As part of a large-scale N-ethyl-N-nitrosourea mutagenesis screen using a wide range of nervous system and behavioral phenotypes, we have identified a number of new circadian mutants in mice. Here, we describe a new short-period circadian mutant, part-time (prtm), which is caused by a lossof-function mutation in the Cryptochrome1 (Cry1) gene. We also describe a long-period circadian mutant named Overtime (Ovtm). Positional cloning and genetic complementation reveal that Ovtm is encoded by the F-box protein FBXL3, a component of the SKP1-CUL1-F-box protein (SCF) E3 ubiquitin ligase complex. The Ovtm mutation causes an isoleucine to threonine (I364T) substitution leading to a loss of function in FBXL3 that interacts specifically with the CRYPTOCHROME (CRY) proteins. In Ovtm mice, expression of the PERIOD proteins PER1 and PER2 is reduced; however, the CRY proteins CRY1 and CRY2 are unchanged. The loss of FBXL3 function leads to a stabilization of the CRY proteins, which in turn leads to a global transcriptional repression of the Per and Cry genes. Thus, Fbxl3
INTRODUCTION
The mechanism of circadian oscillators in mammals is generated by a cell-autonomous autoregulatory transcription-translation feedback loop (Reppert and Weaver 2002; Lowrey and Takahashi 2004; Ko and Takahashi 2006) . In the primary negative feedback loop, the basic helix-loophelix (bHLH)-PAS transcription factors, CLOCK (and its paralog NPAS2) and BMAL1 (ARNTL), dimerize and activate transcription of the Period (Per1, Per2) and Cryptochrome (Cry1, Cry2) genes King et al. 1997; Gekakis et al. 1998; Kume et al. 1999; Bunger et al. 2000; DeBruyne et al. 2007) . As the PER proteins accumulate, they form complexes with the CRY proteins, translocate into the nucleus, and interact with the CLOCK/BMAL1 complex to inhibit their own transcription (Lee et al. 2001) . This leads to a fall in the inhibitory complex through turnover, and the cycle starts again with a new round of CLOCK/BMAL1-activated transcription. Additional pathways in the circadian gene network such as the second negative feedback loop (involving Reverbα) in the positive limb of the oscillator are thought to add robustness to the circadian mechanism (Preitner et al. 2002; Sato et al. 2004) . Finally, posttranslational modifications have critical roles in regulating the turnover, cellular localization, and activity of circadian clock proteins (Lowrey et al. 2000; Eide et al. 2005; Gallego and Virshup 2007) .
Despite this progress, it is clear that a significant number of genes that strongly influence and regulate circadian rhythms in mammals remain to be discovered and identified (Shimomura et al. 2001; Takahashi 2004) . Forward genetic screens have been one of the most effective tools for circadian gene discovery Vitaterna et al. 1994; Takahashi 2004 ), and we have used this approach to screen the mouse genome for circadian rhythm mutants generated in the Neurogenomics Project in the Center for Functional Genomics at Northwestern University (Vitaterna et al. 2006) .
MUTAGENESIS, SCREENING, AND IDENTIFICATION OF THE PRTM and OVTM GENES
In an N-ethyl-N-nitrosourea (ENU) recessive screen using the BTBR T + tf/J (BTBR/J) inbred mouse strain (Siepka and Takahashi 2005) , we identified two mutants with short (21.4 hours) and long (25.8 hours) circadian periods in constant darkness (DD) (Fig. 1) . These two mutants were named part-time (prtm) and Overtime (Ovtm) (Siepka et al. 2007) , respectively. Genetic mapping of prtm places this mutant on chromosome 10 in the region of Cry1 (Fig. 2A) . Complementation tests of prtm with a Cry1 null allele show that prtm is a new allele of Cry1 (Fig. 2B) . Sequencing of the Cry1 gene in prtm mutants reveals a T to C mutation in the second position of the splice donor site of exon 2 causing readthrough and premature termination in intron 2 (Fig. 2C) . Crosses of prtm with Cry2 null mutants to produce double homozygous mutants show that these mice are arrhythmic, similar to that seen in Cry1/Cry2 double-mutant mice (Vitaterna et al. 1999) . Thus, prtm is a loss-of-function allele of Cry1 and serves as a validation of the genetic screen.
The second mutant, Ovtm, maps to a 1.7-cM interval on chromosome 14 (Fig. 3) (Siepka et al. 2007 ). This region corresponds to a 4-Mb interval and contains 18 open reading frames, none of which corresponds to previously known circadian clock genes (Fig. 4A ) (Lowrey and Takahashi 2004) . We sequenced all annotated exons for the 18 candidate genes in the Ovtm interval and found only a single nonsynonymous point mutation within the coding region of Fbxl3. There is a single-base transition from A to G in exon 5 of Fbxl3 in Ovtm mice as compared to wild-type BTBR/J mice. This mutation cosegregated perfectly with the long-period phenotype of Ovtm/Ovtm mice. The point mutation converts amino acid residue 364 from isoleucine to threonine in FBXL3 (Fig. 4A,B) . This isoleucine residue is highly conserved in FBXL3 from vertebrates and in the mouse paralog FBXL21 (Fig. 4B ). FBXL3 is a member of the F-box protein family with leucine-rich repeats (LRR) which is defined by its founding member, SKP2 (S-phase kinase-associated protein-2) (FBXL1) (Jin et al. 2004) . SKP2 is the F-box protein moiety in the SKP1-CUL1-F-box-protein (SCF) SKP2 E3 ubiquitin ligase complex that mediates the recognition ethyl-N-nitrosourea (ENU) (1 x 250 mg/kg) and G 1 offspring were used to breed three-generation pedigrees to make ENU-induced mutations homozygous as described previously (Siepka and Takahashi 2005) and ubiquitination of the CDK2 inhibitor, p27 Kip1 , to target it for proteasomal degradation . FBXL3 has 11 LRRs and can align with SKP2, which has 10 LLRs based on its protein structure; however, the carboxyl termini of SKP2 and FBXL3 are not conserved likely due to the recognition of different substrates (Hao et al. 2005) . The Ovtm I364T mutation occurs in the carboxyl terminus of FBXL3 between LRR10 and LRR11 where the alignment with SKP2 becomes divergent (Fig. 4B) . Because the LRR domains of F-box proteins are involved with substrate recognition with the SCF complex, we hypothesized that the I364T mutation could alter the interaction of FBXL3 with its substrates.
Because we isolated only one mutant allele of Fbxl3, and either a second independent allele, rescue, or functional evidence is required for proof in positional cloning , we used genetic complementation tests to confirm that Ovtm was allelic with Fbxl3. The crosses show that Ovtm and an Fbxl3 gene trap (GT) fail to complement each other, thus providing independent and definitive evidence that Ovtm is an allele of Fbxl3 (Fig. 4C) . Interestingly, the period length of GT/Ovtm mice is indistinguishable from Ovtm homozygotes, suggesting that the Ovtm mutant allele is likely a hypomorphic or loss-of-function allele. 
EFFECTS OF THE OVERTIME MUTATION ON CIRCADIAN CLOCK GENE EXPRESSION
Because FBXL3 is likely a component of an SCF E3 ubiquitin ligase complex, we examined the in vivo expression patterns of circadian clock proteins in mouse tissues to explore whether Ovtm might alter their abundance by affecting degradation. Figure 5A shows expression patterns of the clock proteins, CRY1, CRY2, PER1, PER2, CLOCK, and BMAL1, in liver and cerebellum. In wild-type mice, there were low-amplitude rhythms of CRY1 and CRY2 and high-amplitude rhythms of PER1 and PER2 as reported previously (Lee et al. 2001) . In Ovtm liver tissue, CRY1 and CRY2 protein patterns were not significantly altered; however, PER1 and PER2 levels were significantly reduced (Fig. 4B) . In the cerebellum, the effects of Ovtm were more striking. Although CRY1 levels were not different, CRY2 levels were significantly elevated in Ovtm mice, consistent with the hypothesis that CRY degradation is impaired. In addition, there were very clear reductions in the levels of PER1 and PER2. The reduction of PER1 and PER2 levels in Ovtm mice is unexpected and counterintuitive. We would have expected to see an increase rather than a decrease in protein abundance if the PER proteins were targets of FBXL3 because the Ovtm mutation is a loss-of-function mutation. This suggests that it is unlikely that the PER proteins are targets of FBXL3 and that the reduction in PER levels could occur as a consequence of the negative feedback on CLOCK/BMAL1-dependent transcription.
To explore the reasons for the reduction in PER1 and PER2 protein abundance, we profiled the in vivo circadian mRNA expression patterns for Cry1, Cry2, Per1, Per2, and Dbp in the liver and cerebellum of mice main-254 SIEPKA ET AL. Figure 5C , the Ovtm mutation caused significant reductions in the mRNA abundance of all of these cycling transcripts, with the strongest effects being seen with Cry1 and Per2 in the cerebellum. At the mRNA level, both a delay in the peak time and a reduction in abundance can be seen. Importantly, although CRY1 and CRY2 protein levels were not lower in Ovtm mice, the corresponding mRNA levels for Cry1 and Cry2 are significantly reduced in both tissues. In addition, mRNA levels for the cycling CLOCK target gene, Dbp (Ripperger and Schibler 2006) , were very strongly reduced in Ovtm mice. Thus, the mRNA profiling experiments point to an interesting and unexpected consequence of the Ovtm mutation: a reduction in steady-state mRNA expression of Cry1, Cry2, Per1, Per2, and Dbp, which are all transcriptional targets of the CLOCK/BMAL1 complex (Gekakis et al. 1998; Kume et al. 1999; Yoo et al. 2005; Ripperger and Schibler 2006) .
Comparison of the effects of Ovtm on protein versus mRNA abundance suggests that there are two different effects on the expression of the CRY and PER proteins.
The PER protein levels appear to be reduced as a consequence of reduced transcript levels. In contrast, the CRY protein levels are not reduced even in the face of reduced transcript levels. This suggests that potential reductions in CRY protein levels caused by reduced Cry transcript levels could be compensated by a reduction in protein degradation.
INTERACTION OF OVTM WITH CIRCADIAN CLOCK PROTEINS
The Pagano laboratory has found that FBXL3 targets CRY proteins for ubiquitination and degradation ). To confirm these results and determine whether the Ovtm mutation affects interactions with CRY, we examined the interaction of FBXL3 or OVTM with circadian clock proteins by immunoprecipitation assays. Both FBXL3 and OVTM interacted strongly with native CRY1 and CRY2 proteins. Very weak or no interaction of FBXL3 was seen with PER1 and PER2, especially in comparison with that seen between the PERs and GENETICS OF MOUSE CLOCKS 255 
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βTrCP1, an F-box protein known to interact with the PERs (Fig. 6A ) (Eide et al. 2005; Shirogane et al. 2005) . In all experiments, there was a discernibly stronger interaction of the CRY proteins with FBXL3 relative to OVTM, but the difference was subtle. We also used tagged proteins in coimmunoprecipitation assays in 293A cells which are easily transfected and express relatively low levels of clock proteins. Both FBXL3 and OVTM interacted strongly with CRY1 and CRY2 (Fig. 6B) . To explore the weak interaction of FBXL3 with PER proteins, tagged Per constructs were also tested. All three PER proteins showed interactions with FBXL3 and OVTM, however, the strongest interactions were seen with PER2. Because PER2 interacts very strongly with CRY1 (Griffin et al. 1999; Kume et al. 1999; Lee et al. 2001) , it is likely that the interactions seen here with FBXL3 may be indirect via CRY1.
EFFECTS OF OVTM ON CRY DEGRADATION
To determine whether OVTM is less efficient than FBXL3 in inducing the degradation of CRY1, we compared the effects of FBXL3 and OVTM on the stability of CRY1 following cycloheximide treatment to prevent de novo protein synthesis in transfected cells (Fig. 6C) . In 293A cells, FBXL3 expression leads to the degradation of CRY1, and this degradation is blocked by the 26S proteasomal inhibitor MG132 (Fig. 6C) . OVTM is less effective than FBXL3 in causing CRY1 degradation under these conditions. Interestingly, the turnover of FBXL3 is also 256 SIEPKA ET AL. affected by the OVTM mutation (Fig. 6C, bottom) . FBXL3 is relatively stable with a half-life of greater than 7 hours, whereas OVTM has a much shorter half-life of 2.7 hours (Fig. 6D) . Therefore, there are two effects of the OVTM mutation: a reduction in proteasome-mediated CRY1 degradation and a decreased stability of the OVTM protein itself, both of which could contribute to a loss-offunction phenotype.
To determine whether these changes in CRY1 stability seen in transfected cells are physiological, we used fibroblasts prepared from either wild-type or Ovtm mice and determined the half-lives of native CRY1 and PER2 proteins in these cells. As shown in Figure 6E ,F, the halflife of CRY1 in Ovtm fibroblasts is extremely long (>>9 hours) as compared to wild-type cells (half-life = 5.2 hours). The overall levels of PER2 in Ovtm fibroblasts were very low, similar to that seen in the cerebellum. When the half-life of PER2 was determined, however, there was no detectable difference in the half-life of PER2 in wild-type and Ovtm cells (Fig. 6F) . Thus, these experiments in fibroblasts from wild-type and Ovtm mice show that native CRY1, but not PER2, turnover is specifically altered by the Ovtm mutation.
CONCLUSIONS
We have shown that the ENU-induced Overtime mutant is caused by an I364T mutation in the mouse FBXL3 protein (Siepka et al. 2007 ), a member of the F-box protein with leucine-rich repeats family (Jin et al. 2004) . The OVTM protein is less efficient than FBXL3 in degrading CRY1, thus providing genetic evidence that FBXL3 appears likely to be a primary F-box protein within an SCF E3 ubiquitin ligase complex that targets the CRY proteins for degradation in the proteasome (Fig. 7) . The I364T OVTM mutation lengthens circadian periodicity approximately 2.5 hours in mice. We propose that the phenotypic effects of the Ovtm mutation occur primarily through two mechanisms: (1) loss of FBXL3 function leading to stability of CRY1 protein and (2) repression of CLOCK/BMAL1-dependent transcriptional activation. These two processes lead to a striking reduction in the expression of the PER proteins which is caused by a reduction in transcription of the Per genes. In contrast, the levels of CRY are not reduced by the Ovtm mutation despite lower rates of Cry transcription. Because the transcription of the Cry1 gene is strongly attenuated by the Ovtm mutation, it is surprising that CRY1 protein levels are not lower. The low rate of CRY1 protein degradation in Ovtm tissues must offset the lower synthesis of CRY1 so that the steady-state abundance of CRY1 protein is similar in Ovtm and wild-type mice. Importantly, however, because the turnover rate of CRY1 is reduced, the clearance of CRY1 will be prolonged even if the initial steady-state abundance levels are comparable. This would then lead to a prolongation of the CRY-dependent repression phase of the circadian cycle ). If such a prolongation extended CRY repression for 2-3 hours, the period-lengthening phenotype seen in Ovtm mice would follow as a consequence.
These results highlight the significance of an SCF FBXL3 E3 ubiquitin ligase complex in regulating the stability and kinetics of CRY degradation. The specificity of the FBXL3 interaction with the CRY proteins is striking and
GENETICS OF MOUSE CLOCKS 257
Figure 7. Model of the primary negative feedback loop within the circadian clock of mammals. Diagram shows the primary negative autoregulatory feedback loop that constitutes the circadian oscillator mechanism in mammals. The BMAL1-CLOCK heterodimeric complex activates transcription of the Per1, Per2, Cry1, and Cry2 genes. The PER and CRY proteins accumulate in the cytoplasm and interact with each other and then translocate into the nucleus with CK1δ/ε where the complex interacts with BMAL1-CLOCK to inhibit the transcription of the Per and Cry genes. The turnover of the PER and CRY proteins are selectively regulated by interaction with the F-box proteins, β-TrCP and FBXL3, respectively, to target them for ubiquitination and subsequent degradation by the proteasome.
suggests that additional F-box proteins may regulate other circadian clock components. The first example of an Fbox protein having a role in circadian rhythmicity was the Arabidopsis gene ZEITLUPE (ZTL) that encodes an Fbox protein with an amino-terminal LOV domain and carboxy-terminal kelch repeats (Somers et al. 2000) . ZTL targets the Arabidopsis clock protein, TOC1, for degradation by the proteasome and is thought to regulate circadian period by controlling TOC1 stability (Mas et al. 2003) . In addition, the F-box protein, FKF1, mediates the cyclic degradation of CDF1, a repressor of the photoperiodic gene CONSTANS (Imaizumi et al. 2005) , and the Fbox protein, AFR, is a positive regulator of phytochrome-A-mediated light signaling in Arabidopsis (Harmon and Kay 2003) . FBXL3 is the second example of a mammalian F-box protein regulating the circadian clock proteins. The first example is βTrCP, which has been shown to interact directly with the PER proteins (Eide et al. 2005; Shirogane et al. 2005) . Evidence for βTrCP in the circadian pathway first emerged from Drosophila in which it was shown that Slimb, the ortholog of βTrCP, regulated circadian expression of PER and TIM (Grima et al. 2002; Ko et al. 2002) . Interestingly, in Neurospora, the ortholog of βTrCP, FWD1, regulates the degradation of the clock protein, FREQUENCY (He et al. 2003) . More recently, JETLAG, the Drosophila ortholog of Fbxl15, has been shown to have a critical role in lightinduced TIM degradation by the proteasome (Koh et al. 2006 ). In Drosophila, two different SCF complexes appear to control TIM levels: a circadian pathway involving Slimb and a light-dependent pathway involving JET (Koh et al. 2006 ). It will be interesting see whether similar types of mechanisms are conserved in mammals. Because of the differences in the roles of the PER and CRY proteins in Drosophila and in mammals (Allada et al. 2001; Young and Kay 2001) , where CRY is primarily a circadian repressor (not a photoreceptor), FBXL3 appears to function in a circadian SCF complex-mediated pathway. Unlike Drosophila PER, the PER1 and PER2 proteins in mammals are transcriptionally induced by light in the suprachiasmatic nucleus (SCN). It will be interesting to see whether βTrCP functions in a circadian or in a light-dependent SCF pathway for PER degradation (analogous to the TIM protein in Drosophila). Using a forward genetics approach in mice, we have identified FBXL3 as a new molecular component of the negative feedback loop that generates circadian rhythmicity. Ironically, in the same screen, we found a second mutation in Cry1, the substrate for FBXL3. These experiments highlight the important role of CRY1 in the regulation of circadian period in which loss of function leads to shortened periodicity, whereas its overexpression by virtue of stabilization leads to lengthened periodicity.
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